{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:33:54Z","timestamp":1792895634280,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.drugalcdep.2005.07.001","type":"journal-article","created":{"date-parts":[[2005,8,25]],"date-time":"2005-08-25T11:29:37Z","timestamp":1124969377000},"page":"215-220","source":"Crossref","is-referenced-by-count":35,"title":["Morbidity and mortality in patients testing positively for the presence of anabolic androgenic steroids in connection with receiving medical care"],"prefix":"10.1016","volume":"81","author":[{"given":"Anna","family":"Petersson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Garle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Granath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingemar","family":"Thiblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2005.07.001_bib1","first-page":"4317","article-title":"Anabolic steroid withdrawal depression: a case report","volume":"41","author":"Allnutt","year":"1994","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib2","first-page":"4143","article-title":"Anabolic steroids and acute schizophrenic episode","volume":"41","author":"Anitto","year":"1980","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib3","first-page":"342","article-title":"Anabolic-androgenic steroids as a gateway to opioid dependence","volume":"18","author":"Arvary","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/1054-139X(94)90537-1","article-title":"Stability of the relationships between anabolic steroid use and multiple substance use among adolescents","volume":"15","author":"Durant","year":"1994","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1542\/peds.96.1.23","article-title":"Anabolic-steroid use, strength training, and multiple drug use among adolescents in the United States","volume":"96","author":"DuRant","year":"1995","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.drugalcdep.2005.07.001_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1054-139X(01)00414-1","article-title":"Steroid use among adolescents: finding from project EAT","volume":"30","author":"Irving","year":"2002","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4088\/JCP.v64n0208","article-title":"Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem?","volume":"64","author":"Kanayama","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/14034948980260010201","article-title":"Doping among high school students in Uppsala, Sweden: a presentation of the attitudes, distribution, side effects, and extent of use","volume":"26","author":"Kindlundh","year":"1998","journal-title":"Scand. J. Soc. Med."},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1360-0443.1999.9445439.x","article-title":"Factors associated with adolescent use of doping agents: anabolic-androgenic steroids","volume":"94","author":"Kindlundh","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib10","first-page":"876","article-title":"Prevalence of androgenic-anabolic steroid use in adolescents in two regions of South Africa","volume":"88","author":"Lambert","year":"1998","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00042752-199501000-00005","article-title":"Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users","volume":"5","author":"Malone","year":"1995","journal-title":"Clin. J. Sport Med."},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/eurpub\/11.2.195","article-title":"The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden","volume":"11","author":"Nilsson","year":"2001","journal-title":"Eur. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bjsm.26.4.219","article-title":"A case of affective disorder associated with the misuse of \u2018anabolic steroids\u2019","volume":"26","author":"Perry","year":"1992","journal-title":"Brit. J. Sports Med."},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archpsyc.1994.03950050035004","article-title":"Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes","volume":"51","author":"Pope","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-2000-304","article-title":"Increased premature mortality of competitive powerlifters suspected to have used anabolic agents","volume":"21","author":"P\u00e4rssinen","year":"2000","journal-title":"Int. J. Sports Med."},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuroscience.2004.08.002","article-title":"Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstendiol and 17beta-estradiol","volume":"129","author":"Reddy","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pbb.2004.04.020","article-title":"Androgens in the hippocampus can alter, and be altered by ictal activity","volume":"78","author":"Rhodes","year":"2004","journal-title":"Pharmacol. Biochem Behav."},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib18","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/ajhp\/53.17.2068","article-title":"Anabolic steroid use among adolescents in Nebraska schools","volume":"53","author":"Scott","year":"1996","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2005.07.001_bib19","first-page":"73","article-title":"Acute paranoid psychotic symptoms after i.m. injection of nandrolone [Article in German]","volume":"30","author":"Teuber","year":"2003","journal-title":"Psychiatry Prax."},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1472-8206.2004.00298.x","article-title":"Pharmacoepidemiology of anabolic androgenic steroids: a review","volume":"19","author":"Thiblin","year":"2004","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.15288\/jsa.2001.62.5","article-title":"Use of anabolic-androgenic steroids in adolescence: winning, looking good or being bad?","volume":"62","author":"Wichstr\u00f6m","year":"2001","journal-title":"J. Stud. Alcohol."},{"key":"10.1016\/j.drugalcdep.2005.07.001_bib22","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jama.270.10.1217","article-title":"Anabolic-androgenic steroid use in the United States","volume":"270","author":"Yesalis","year":"1993","journal-title":"JAMA"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687160500219X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687160500219X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T08:49:10Z","timestamp":1683190150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687160500219X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S037687160500219X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2005.07.001","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}